FGF19
FGF19 (fibroblast growth factor 19) is a secreted member of the fibroblast growth factor family that suppresses bile acid biosynthesis and stimulates glucose uptake in adipocytes. It is a high affinity, heparin-dependent ligand for FGFR4. Browse Assay Genie's current range of FGF19 research reagents below, or read on for the biology behind the target.
FGF19 is involved in the suppression of bile acid biosynthesis. It acts by down-regulating CYP7A1 expression, following positive regulation of the JNK and ERK1/2 cascades. It also stimulates glucose uptake in adipocytes. Its activity requires the presence of KLB and FGFR4, and the NCBI Gene summary describes it as a high affinity, heparin-dependent ligand for FGFR4.
The FGF19 protein is secreted and belongs to the heparin-binding growth factors family. The FGF19 gene encodes a member of the wider fibroblast growth factor (FGF) family, whose members possess broad mitogenic and cell survival activities. These proteins are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, and tumour growth and invasion.
Expression of the gene was detected only in foetal, but not adult, brain tissue. Work on the chick homologue showed that synergistic interaction with Wnt-8c is required for the initiation of inner ear development. Together, these findings link fibroblast growth factor 19 to both developmental biology and metabolic regulation, making it a useful target for studies of FGFR4 and KLB signalling.
FGF19 suppresses bile acid biosynthesis by down-regulating CYP7A1 expression, making it a key factor in studies of bile acid control.
FGF19 stimulates glucose uptake in adipocytes, which makes it relevant to research on adipocyte metabolism.
FGF19 activity requires KLB and FGFR4, and it engages the JNK and ERK1/2 cascades, supporting receptor complex and pathway analysis.
FGF family members act in embryonic development, and chick FGF19 cooperates with Wnt-8c in initiating inner ear development.
FGF19 is involved in suppressing bile acid biosynthesis through down-regulation of CYP7A1 expression, following positive regulation of the JNK and ERK1/2 cascades. It also stimulates glucose uptake in adipocytes. Its activity requires the presence of KLB and FGFR4.
FGF19 is a member of the fibroblast growth factor family and belongs to the heparin-binding growth factors family. It is a high affinity, heparin-dependent ligand for FGFR4, and its activity requires both FGFR4 and KLB.
The NCBI Gene summary reports that expression was detected only in foetal, not adult, brain tissue. A chick homologue has been shown to act synergistically with Wnt-8c in initiating inner ear development, indicating conserved developmental roles. Check the datasheet of any product for its validated reactivity.
Other fibroblast growth factors, FGF-binding proteins and FGF receptors with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O95750; product specifications from Assay Genie datasheets.